Ono Pharmaceutical Co., Ltd. (OPHLY)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
| Previous close | 4.8900 |
| Open | 4.8000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 4.7050 - 4.9300 |
| 52-week range | 4.7050 - 6.8500 |
| Volume | |
| Avg. volume | 114,469 |
| Market cap | 6.865B |
| Beta (5Y monthly) | 0.18 |
| PE ratio (TTM) | 8.40 |
| EPS (TTM) | 0.5700 |
| Earnings date | N/A |
| Forward dividend & yield | 0.18 (3.68%) |
| Ex-dividend date | 28 Sept 2023 |
| 1y target est | N/A |
- Thomson Reuters StreetEvents
Q4 2023 Cue Biopharma Inc Earnings Call
Q4 2023 Cue Biopharma Inc Earnings Call
- GuruFocus.com
Fate Therapeutics Inc (FATE) Reports Fourth Quarter and Full Year 2023 Financial Results
Advancements in Clinical Trials and Strong Cash Position Highlighted
PR NewswireOno Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that in order to accelerate the open innovation, it has increased its investment pool from US$100 million to US$200 million to continue strategic investment in Ono Venture Investment Fund I, L.P. ("OVI FI"), which was established as a corporate venture capital fund in CA, USA in May 2020.
© 2024 Yahoo. All rights reserved.